WJ Schonewille, CAC Wijman, P Michel… - The Lancet …, 2009 - thelancet.com
Background Treatment strategies for acute basilar artery occlusion (BAO) are based on case series and data that have been extrapolated from stroke intervention trials in other …
RA Ahmed, AA Dmytriw, AB Patel… - Interventional …, 2023 - journals.sagepub.com
Basilar artery occlusion (BAO) is an infrequent but often fatal subtype of stroke. Predicting outcomes and selecting patients for endovascular therapy (EVT) remains challenging …
TA Baird, KW Muir, I Bone - Neurocritical care, 2004 - Springer
Basilar artery occlusion is assumed to carry a grave prognosis, with mortality rates of up to 90%. Diagnosis is often delayed, or even missed, as a result of the variety of clinical …
HP Mattle, M Arnold, PJ Lindsberg… - The Lancet …, 2011 - thelancet.com
The clinical presentation of basilar artery occlusion (BAO) ranges from mild transient symptoms to devastating strokes with high fatality and morbidity. Often, non-specific …
W Yu, V Kostanian, M Fisher - Stroke, 2007 - Am Heart Assoc
Background and Purpose—Acute basilar artery occlusion portends high risk of stroke and death. Thrombolysis or endovascular therapy has been limited to patients who present …
G Devuyst, J Bogousslavsky, R Meuli… - Archives of …, 2002 - jamanetwork.com
Background Basilar artery occlusion (BAO) is associated with a high mortality rate, although cases with spontaneous favorable outcomes have recently been reported, and basilar artery …
WJ Schonewille, A Algra, J Serena… - Journal of Neurology …, 2005 - jnnp.bmj.com
Background: Most data on the outcome of basilar artery occlusion are from recent case series of patients treated with intra-arterial thrombolysis. The limited knowledge on the …
T Brandt, MS Pessin, ES Kwan, LR Caplan - Cerebrovascular Diseases, 1995 - karger.com
Basilar artery (BA) occlusion is generally believed to have a high mortality. A favorable outcome is rarely reported. A consecutive series of 20 survivors with angiographically …
S Nagel, PD Schellinger, M Hartmann, E Juettler… - Stroke, 2009 - Am Heart Assoc
Background and Purpose—While intravenous recombinant tissue plasminogen activator (rt- PA) has been approved for acute stroke therapy within 3 hours, the optimum management of …